Accolade, Inc. (NASDAQ:ACCD) Given Consensus Recommendation of “Hold” by Brokerages

Accolade, Inc. (NASDAQ:ACCD) has received an average recommendation of “Hold” from the fourteen ratings firms that are covering the stock, MarketBeat reports. Thirteen research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $6.51.

A number of research analysts have commented on the stock. Piper Sandler lowered shares of Accolade from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 5th. Stephens restated an “equal weight” rating and issued a $7.03 price objective on shares of Accolade in a research note on Wednesday, February 12th.

Accolade Stock Performance

NASDAQ ACCD opened at $7.02 on Tuesday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.63 and a current ratio of 2.63. The firm has a market cap of $575.59 million, a PE ratio of -3.12 and a beta of 2.10. Accolade has a one year low of $3.08 and a one year high of $7.70. The firm’s fifty day moving average is $7.01 and its two-hundred day moving average is $5.92.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Longfellow Investment Management Co. LLC acquired a new position in shares of Accolade during the first quarter worth about $74,000. Laird Norton Wetherby Trust Company LLC purchased a new stake in Accolade during the fourth quarter worth about $38,000. Ground Swell Capital LLC purchased a new stake in Accolade during the first quarter worth about $86,000. Boothbay Fund Management LLC purchased a new stake in Accolade during the fourth quarter worth about $43,000. Finally, Wealth Enhancement Advisory Services LLC purchased a new stake in Accolade during the fourth quarter worth about $48,000. 84.99% of the stock is currently owned by institutional investors and hedge funds.

Accolade Company Profile

Accolade, Inc, together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and primary care physicians.